A retrospective, longitudinal analysis assessing current use of anticholinergic medications in a large naturalistic sample of psychiatric patients.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Amantadine (Primary) ; Amitriptyline (Primary) ; Biperiden (Primary) ; Clomipramine (Primary) ; Clozapine (Primary) ; Darifenacin (Primary) ; Dimenhydrinate (Primary) ; Diphenhydramine (Primary) ; Doxepin (Primary) ; Fesoterodine (Primary) ; Glycopyrrolate (Primary) ; Hydroxyzine (Primary) ; Loxapine (Primary) ; Nortriptyline (Primary) ; Olanzapine (Primary) ; Oxcarbazepine (Primary) ; Oxybutynin (Primary) ; Oxycodone (Primary) ; Paroxetine (Primary) ; Pimozide (Primary) ; Pirenzepine (Primary) ; Promethazine (Primary) ; Scopolamine (Primary) ; Scopolamine butylbromide (Primary) ; Solifenacin (Primary) ; Thioridazine (Primary) ; Tiotropium bromide (Primary) ; Trihexyphenidyl (Primary) ; Trimipramine (Primary) ; Trospium chloride (Primary)
- Indications Psychiatric disorders
- Focus Therapeutic Use
- 08 Nov 2021 New trial record